Τίτλος:
Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Tampaki, E.C.
Tampakis, A.
Droeser, R.
Patsouris, E.
Kouraklis, G.
Περιοδικό:
Cancer Biology and Therapy
Εκδότης:
Taylor and Francis Inc.
Λέξεις-κλειδιά:
cabozantinib; placebo; vandetanib; anilide; cabozantinib; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; piperidine derivative; pyridine derivative; quinazoline derivative, apoptosis; artery thrombosis; bleeding; bleeding disorder; cancer patient; cancer stem cell; cardiovascular disease; diarrhea; digestive system fistula; digestive system perforation; drug approval; epithelial mesenchymal transition; European Medicines Agency; fatigue; follow up; gastrointestinal disease; hand foot syndrome; human; hypertension; interstitial lung disease; jaw osteonecrosis; kidney failure; Letter; mental disease; metabolic disorder; mouth pain; neurologic disease; overall survival; oxidative phosphorylation; pneumonia; posterior reversible encephalopathy syndrome; progression free survival; QT prolongation; quality of life; rash; side effect; skin disease; stomatitis; sudden death; thyroid medullary carcinoma; torsade des pointes; vein thrombosis; visual disorder; wound healing; mitochondrion; thyroid tumor, Anilides; Humans; Mitochondria; Piperidines; Pyridines; Quinazolines; Thyroid Neoplasms
DOI:
10.1080/15384047.2018.1433495
